UNH Factor-Based Stock Analysis

Validea's guru fundamental report indicates that UnitedHealth Group (UNH) receives a 69% rating based on their Growth Investor model, which is based on the strategy of Martin Zweig. The model favors UNH due to its persistent accelerating earnings and sales growth, reasonable valuations, and low debt, though the report notes failures in quarterly earnings one year ago, earnings persistence, and long-term EPS growth. Zweig's historical investment performance showed an average return of 15.9 percent per year.

Analysis

UnitedHealth Group Inc. (UNH) has received a 69% rating from Validea's Growth Investor model, based on Martin Zweig's strategy, which seeks growth stocks with persistent accelerating earnings, strong sales growth, reasonable valuations, and low debt. This score indicates a moderate alignment with the strategy's criteria, falling short of the 80% threshold that typically signals notable interest. UNH, a large-cap value stock in the Insurance (Accident & Health) sector, passed several key tests including P/E ratio, revenue growth in relation to EPS growth, sales growth rate, current quarter earnings, positive earnings growth rate for the current quarter, and EPS growth for the current quarter exceeding both the prior three quarters and the historical growth rate. Insider transactions also received a 'PASS'. However, the company failed on critical criteria related to consistency and longer-term performance, specifically: quarterly earnings one year ago, earnings growth rate for the past several quarters, earnings persistence, and long-term EPS growth. This mixed performance suggests current strengths but raises questions about the sustainability and acceleration of its growth trajectory as viewed through the lens of this specific investment model.

Key Decisions for Investors

• Investors should recognize that while UNH passes several current growth and valuation metrics under the Zweig model, the 69% score and failures in long-term earnings persistence and growth consistency warrant careful consideration, particularly for investors prioritizing sustained, accelerating growth.
• It would be prudent to investigate the underlying reasons for the 'FAIL' ratings on historical and long-term earnings metrics to assess if these are temporary or indicative of more persistent challenges to its growth profile.
• Monitor future earnings releases for improvements in the 'FAIL' categories, such as earnings persistence and long-term EPS growth, which could strengthen the investment case according to this growth-oriented strategy.